Evaluation of the Effectiveness of Immunomodulatory Therapy in Chronic Obstructive Pulmonary Disease
The purpose of our study was to evaluate the effectiveness of sodium deoxyribonucleate (Derinat, solution for intramuscular injection) in combination with standard therapy in the treatment of COPD Group C patients in outpatient settings. Materials and Methods: The study included 80 patients (43 me...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
International Medical Research and Development Corporation
2019-12-01
|
| Series: | International Journal of Biomedicine |
| Subjects: | |
| Online Access: | http://ijbm.org/articles/i36/ijbm_9(4)_oa5.pdf |
| _version_ | 1818269522286608384 |
|---|---|
| author | Anna Zuikova Olga Krasnorutskaya Julia Kotova Daniil Bugrimov Natalia Strahova Elena Esina Olga Kashaeva Olga Paevskaya |
| author_facet | Anna Zuikova Olga Krasnorutskaya Julia Kotova Daniil Bugrimov Natalia Strahova Elena Esina Olga Kashaeva Olga Paevskaya |
| author_sort | Anna Zuikova |
| collection | DOAJ |
| description | The purpose of our study was to evaluate the effectiveness of sodium deoxyribonucleate (Derinat, solution for intramuscular injection) in combination with standard therapy in the treatment of COPD Group C patients in outpatient settings.
Materials and Methods: The study included 80 patients (43 men and 37 women) with COPD (Group C), mean age of 51.7±1.4 years. Blood sampling for the study was carried out 3 times—before the start of therapy, and on days 5 and 15. Using monoclonal antibodies, we determined the number of lyphocytes carrying markers CD3+, CD+, CD8+, and CD72+. The quality of life (QL) indicators were evaluated using the St. George’s Respiratory Questionnaire (SGRQ). For at least 15 days, patients received standard COPD therapy. All patients were divided into 2 groups: Group 1 included 41 patients who received Derinat 75 mg intramuscularly once daily for 5 days; then - 5 injections with an interval of 48 hours against the background of standard therapy. Group 2 included 39 patients who continued to receive standard COPD therapy.
Results: The inclusion of Derinat in the complex therapy of COPD contributed to the normalization of the T-cell to B-cell ratio, an increase in the number of T suppressors. Assessing the clinical effects of combination therapy with the inclusion of the studied drug, a marked decrease in shortness of breath, cough, and the amount of sputum excreted can be noted in comparison with standard therapy. The improvement of the immunological status and clinical indicators against the background of complex therapy was accompanied by an increase in QL. |
| first_indexed | 2024-12-12T20:55:43Z |
| format | Article |
| id | doaj.art-757781501a6e4cf88821acb0b9bbd996 |
| institution | Directory Open Access Journal |
| issn | 2158-0510 2158-0529 |
| language | English |
| last_indexed | 2024-12-12T20:55:43Z |
| publishDate | 2019-12-01 |
| publisher | International Medical Research and Development Corporation |
| record_format | Article |
| series | International Journal of Biomedicine |
| spelling | doaj.art-757781501a6e4cf88821acb0b9bbd9962022-12-22T00:12:19ZengInternational Medical Research and Development CorporationInternational Journal of Biomedicine2158-05102158-05292019-12-019430030310.21103/Article9(4)_OA5Evaluation of the Effectiveness of Immunomodulatory Therapy in Chronic Obstructive Pulmonary DiseaseAnna Zuikova0Olga Krasnorutskaya1Julia Kotova2Daniil Bugrimov3Natalia Strahova4Elena Esina5Olga Kashaeva6Olga Paevskaya7Voronezh State Medical University named after N.N. Burdenko; Voronezh, RussiaVoronezh State Medical University named after N.N. Burdenko; Voronezh, RussiaVoronezh State Medical University named after N.N. Burdenko; Voronezh, RussiaVoronezh State Medical University named after N.N. Burdenko; Voronezh, RussiaVoronezh State Medical University named after N.N. Burdenko; Voronezh, RussiaVoronezh State Medical University named after N.N. Burdenko; Voronezh, RussiaMoscow State University of Medicine and Dentistry named after A. I. Evdokimov; Moscow, RussiaI.M. Sechenov First Moscow State Medical University (Sechenov University;, Moscow, RussiaThe purpose of our study was to evaluate the effectiveness of sodium deoxyribonucleate (Derinat, solution for intramuscular injection) in combination with standard therapy in the treatment of COPD Group C patients in outpatient settings. Materials and Methods: The study included 80 patients (43 men and 37 women) with COPD (Group C), mean age of 51.7±1.4 years. Blood sampling for the study was carried out 3 times—before the start of therapy, and on days 5 and 15. Using monoclonal antibodies, we determined the number of lyphocytes carrying markers CD3+, CD+, CD8+, and CD72+. The quality of life (QL) indicators were evaluated using the St. George’s Respiratory Questionnaire (SGRQ). For at least 15 days, patients received standard COPD therapy. All patients were divided into 2 groups: Group 1 included 41 patients who received Derinat 75 mg intramuscularly once daily for 5 days; then - 5 injections with an interval of 48 hours against the background of standard therapy. Group 2 included 39 patients who continued to receive standard COPD therapy. Results: The inclusion of Derinat in the complex therapy of COPD contributed to the normalization of the T-cell to B-cell ratio, an increase in the number of T suppressors. Assessing the clinical effects of combination therapy with the inclusion of the studied drug, a marked decrease in shortness of breath, cough, and the amount of sputum excreted can be noted in comparison with standard therapy. The improvement of the immunological status and clinical indicators against the background of complex therapy was accompanied by an increase in QL.http://ijbm.org/articles/i36/ijbm_9(4)_oa5.pdfsodium deoxyribonucleatepro-inflammatory mediatorsimmunomodulatory therapy |
| spellingShingle | Anna Zuikova Olga Krasnorutskaya Julia Kotova Daniil Bugrimov Natalia Strahova Elena Esina Olga Kashaeva Olga Paevskaya Evaluation of the Effectiveness of Immunomodulatory Therapy in Chronic Obstructive Pulmonary Disease International Journal of Biomedicine sodium deoxyribonucleate pro-inflammatory mediators immunomodulatory therapy |
| title | Evaluation of the Effectiveness of Immunomodulatory Therapy in Chronic Obstructive Pulmonary Disease |
| title_full | Evaluation of the Effectiveness of Immunomodulatory Therapy in Chronic Obstructive Pulmonary Disease |
| title_fullStr | Evaluation of the Effectiveness of Immunomodulatory Therapy in Chronic Obstructive Pulmonary Disease |
| title_full_unstemmed | Evaluation of the Effectiveness of Immunomodulatory Therapy in Chronic Obstructive Pulmonary Disease |
| title_short | Evaluation of the Effectiveness of Immunomodulatory Therapy in Chronic Obstructive Pulmonary Disease |
| title_sort | evaluation of the effectiveness of immunomodulatory therapy in chronic obstructive pulmonary disease |
| topic | sodium deoxyribonucleate pro-inflammatory mediators immunomodulatory therapy |
| url | http://ijbm.org/articles/i36/ijbm_9(4)_oa5.pdf |
| work_keys_str_mv | AT annazuikova evaluationoftheeffectivenessofimmunomodulatorytherapyinchronicobstructivepulmonarydisease AT olgakrasnorutskaya evaluationoftheeffectivenessofimmunomodulatorytherapyinchronicobstructivepulmonarydisease AT juliakotova evaluationoftheeffectivenessofimmunomodulatorytherapyinchronicobstructivepulmonarydisease AT daniilbugrimov evaluationoftheeffectivenessofimmunomodulatorytherapyinchronicobstructivepulmonarydisease AT nataliastrahova evaluationoftheeffectivenessofimmunomodulatorytherapyinchronicobstructivepulmonarydisease AT elenaesina evaluationoftheeffectivenessofimmunomodulatorytherapyinchronicobstructivepulmonarydisease AT olgakashaeva evaluationoftheeffectivenessofimmunomodulatorytherapyinchronicobstructivepulmonarydisease AT olgapaevskaya evaluationoftheeffectivenessofimmunomodulatorytherapyinchronicobstructivepulmonarydisease |